Collecting the data for, and developing a predictive model to identify lapse and relapse to support people who want to change their relationship with alcohol

心灵健康人工智能是一家数字治疗初创公司，为消费者和临床医生提供尖端科学和技术。我们通过机器学习生成的预测模型，为希望改变有害行为和自我管理慢性健康状况的个人提供支持。我们拥有一支多元化的英国创始团队，在临床、商业和技术领域拥有专业知识。我们的综合专业经验提供了丰富的关系，具有现实的市场和机构投资途径，以及真正的扩展潜力。我们的第一款产品是alma，这是一款帮助用户战胜渴望和戒酒的移动应用程序。酒精消费与60多种疾病有关，但尽管几十年来已经有了一系列干预措施，但酒精依赖的危险护理状态意味着90%的人在五年内会复发。在这个具体的项目中，我们寻求招募用户，建立一个足够大的数据集，为能够预测负面健康结果的算法提供信息，包括渴望、失效、完全复发和服务脱离。我们正在与行为科学、预测模型和数字治疗领域的全球前沿学者合作。我们产品的价值主张得到了利益相关者团体的认可，包括寻求戒酒的人，以及保险和制药等相关行业的临床医生和专业人士。

Mind Health AI is a digital therapeutics start up, making cutting-edge science and technology accessible to both consumers and clinicians. We support individuals who want to change harmful behaviours and self--manage chronic health conditions, via predictive models generated by machine learning.We have a diverse, UK-based founding team with expertise in clinical, commercial and technical domains. Our combined professional experience provides a wealth of relationships, with realistic routes to market and institutional investment, and real potential for scaling.Our first product is alma, a mobile application which helps users beat cravings and quit drinking. Alcohol consumption is linked as a causal factor to more than 60 diseases, but although a range of interventions has been available for decades, the parlous state of care for alcohol dependency means that 90% of people who go through rehab relapse within five years. On this specific project, we seek to recruit users, building a dataset large enough to inform algorithms that can predict negative health outcomes, including cravings, lapse, full relapse and service disengagement.We are working with academics at the global forefront of their fields in behavioural science, predictive models and digital therapeutics. The value proposition of our product has been validated by stakeholder groups, including people seeking to quit drinking, as well as clinicians and professionals in related industries such as insurance and pharmaceuticals.